Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane A Mitchell

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?Timothy D Warner, Jane A Mitchell
Pulmonary Circulation|October 24, 2018
PPARβ/δ a potential target in pulmonary hypertension blighted by cancer riskJane A Mitchell, David Bishop-Bailey
British Journal of Pharmacology|August 26, 2009
Targeting PPAR receptors in the airway for the treatment of inflammatory lung diseaseMaria G Belvisi, Jane A Mitchell
European Journal of Pharmacology|August 9, 2002
Nitric oxide supports atrial function in sepsis: relevance to side effects of inhibitors in shockSusanna Price, Timothy W Evans, Jane A Mitchell
The Journal of Clinical Investigation|September 15, 2023
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosisJames May, Jane A Mitchell, R Gisli Jenkins
The Lancet. Respiratory Medicine|April 11, 2014
Use of interferon beta for acute respiratory distress syndrome: proceed with cautionPeter M George, S John Wort, Jane A Mitchell
European Journal of Pharmacology|December 14, 2004
Not so EEZE: the 'EDHF' antagonist 14, 15 epoxyeicosa-5(Z)-enoic acid has vasodilator properties in mesenteric arteriesLouise S Harrington, John R Falck, Jane A Mitchell
The New England Journal of Medicine|April 18, 2014
Proteome-wide analysis and CXCL4 in systemic sclerosisPeter M George, S John Wort, Jane A Mitchell
Circulation|February 19, 2015
Letter by Reed et al regarding article, "Proteomic analysis implicates translationally controlled tumor protein as a novel mediator of occlusive vascular remodeling in pulmonary arterial hypertension"Daniel M Reed, Peter M George, Jane A Mitchell
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2006
COX-2 in cardiovascular diseaseDavid Bishop-Bailey, Jane A Mitchell, Timothy D Warner
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?Timothy D Warner, Jane A Mitchell
Pulmonary Circulation|October 24, 2018
PPARβ/δ a potential target in pulmonary hypertension blighted by cancer riskJane A Mitchell, David Bishop-Bailey
British Journal of Pharmacology|August 26, 2009
Targeting PPAR receptors in the airway for the treatment of inflammatory lung diseaseMaria G Belvisi, Jane A Mitchell
European Journal of Pharmacology|August 9, 2002
Nitric oxide supports atrial function in sepsis: relevance to side effects of inhibitors in shockSusanna Price, Timothy W Evans, Jane A Mitchell
The Journal of Clinical Investigation|September 15, 2023
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosisJames May, Jane A Mitchell, R Gisli Jenkins
The Lancet. Respiratory Medicine|April 11, 2014
Use of interferon beta for acute respiratory distress syndrome: proceed with cautionPeter M George, S John Wort, Jane A Mitchell
European Journal of Pharmacology|December 14, 2004
Not so EEZE: the 'EDHF' antagonist 14, 15 epoxyeicosa-5(Z)-enoic acid has vasodilator properties in mesenteric arteriesLouise S Harrington, John R Falck, Jane A Mitchell
The New England Journal of Medicine|April 18, 2014
Proteome-wide analysis and CXCL4 in systemic sclerosisPeter M George, S John Wort, Jane A Mitchell
Circulation|February 19, 2015
Letter by Reed et al regarding article, "Proteomic analysis implicates translationally controlled tumor protein as a novel mediator of occlusive vascular remodeling in pulmonary arterial hypertension"Daniel M Reed, Peter M George, Jane A Mitchell
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2006
COX-2 in cardiovascular diseaseDavid Bishop-Bailey, Jane A Mitchell, Timothy D Warner
Pageof 15